ArticleDiscover oncology2024

STARD7 could be an immunological and prognostic biomarker: from pan-cancer analysis to hepatocellular carcinoma validation.

Jie Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.